Cargando…
Comment on Aldén et al. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 2022, 44, 1115–1126
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164063/ https://www.ncbi.nlm.nih.gov/pubmed/35723371 http://dx.doi.org/10.3390/cimb44040113 |
| _version_ | 1784720055665164288 |
|---|---|
| author | Merchant, Hamid A. |
| author_facet | Merchant, Hamid A. |
| author_sort | Merchant, Hamid A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9164063 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91640632022-06-04 Comment on Aldén et al. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 2022, 44, 1115–1126 Merchant, Hamid A. Curr Issues Mol Biol Comment MDPI 2022-04-11 /pmc/articles/PMC9164063/ /pubmed/35723371 http://dx.doi.org/10.3390/cimb44040113 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Comment Merchant, Hamid A. Comment on Aldén et al. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 2022, 44, 1115–1126 |
| title | Comment on Aldén et al. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 2022, 44, 1115–1126 |
| title_full | Comment on Aldén et al. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 2022, 44, 1115–1126 |
| title_fullStr | Comment on Aldén et al. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 2022, 44, 1115–1126 |
| title_full_unstemmed | Comment on Aldén et al. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 2022, 44, 1115–1126 |
| title_short | Comment on Aldén et al. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 2022, 44, 1115–1126 |
| title_sort | comment on aldén et al. intracellular reverse transcription of pfizer biontech covid-19 mrna vaccine bnt162b2 in vitro in human liver cell line. curr. issues mol. biol. 2022, 44, 1115–1126 |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164063/ https://www.ncbi.nlm.nih.gov/pubmed/35723371 http://dx.doi.org/10.3390/cimb44040113 |
| work_keys_str_mv | AT merchanthamida commentonaldenetalintracellularreversetranscriptionofpfizerbiontechcovid19mrnavaccinebnt162b2invitroinhumanlivercelllinecurrissuesmolbiol20224411151126 |